Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling

Patients with heavily pretreated advanced cancer or with rare tumors are difficult to treat. Molecular profiling (MP) of tumors to identify biomarkers that predict potential outcomes with individual therapies is an emerging strategy to guide treatment decisions. Patients with rare tumors for which s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Andrew, Byrne, Aisling, Marinova, Mira, Hayden, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972920/
https://www.ncbi.nlm.nih.gov/pubmed/27525268
http://dx.doi.org/10.1155/2016/4627214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972920/
https://www.ncbi.nlm.nih.gov/pubmed/27525268
http://dx.doi.org/10.1155/2016/4627214

Ejemplares similares